Deep vein thrombosis. Color duplex scan of DVT Venogram shows DVT.

Slides:



Advertisements
Similar presentations
Venous Thrombo-embolism In Pregnancy
Advertisements

DEEP VEIN THROMBOSIS.
Venous thromboembolic diseases: Deep vein thrombosis
Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP
Venous Thromboembolism: Risk Assessment and Prophylaxis
Pulmonary Embolism Diagnosis, Treatment, and Prevention Philip Keith March 26, 2008.
Brian M. Johnson, MD CCRMC PBL 11/7/12
Dr Narisha Ramparsad Department of Haematology and Molecular Medicine
1 THROMBOPHILIA. 2 Thrombophilia is technical term for hypercoagulable state Thrombosis (arterial or venous) is produced by a shift in the balance between.
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Results: 1.Progression of thrombus length and volume (40% vs. 28%; P
Long-Term Outcome After Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (The CaVenT Study):
Antithrombotic Therapy for Venous Thromboembolic Diseases
Joint Hospital Surgical Grand Round
Prophylaxis of Venous Thromboembolism
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
Thrombophilia. Now considered a multicausal disease, with an interplay of acquired and genetic thrombotic risk factors Approximately half of venous thromboembolic.
Increasingly, women who are asymptomatic present in pregnancy with a known thrombophilia, typically detected because of screening following identification.
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
Approximately 600,000 new cases are diagnosed in the U.S. each year Thrombus formation in deep veins of legs or thighs Tibial veins, soleal/gastrocnemius.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Unprovoked DVT in a young patient
DEEP VENOUS THROMBOSIS
Volume 359: November 6, 2008 Number 19November 6, 2008.
DVT: Symptoms and work-up Sean Stoneking. DVT Epidemilogy Approximately 600,0000 new cases of DVT each year 50% in hospitalized patients or nursing home.
DR FAROOQ AHMAD RANA ASSISTANT PROFESSOR SURGERY
Chapter Ten Venous Disease Coalition Hypercoagulability VTE Toolkit.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
For Best Viewing:. Open in Slide Show Mode Click on icon. or
Pulmonary Embolism and Infarction
Venous Thromboembolism
7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
Pulmonary Embolism Treatment in Cancer - Is It Different 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF.
Pulmonary Embolism. Introduction  Pulmonary Embolism is a complication of underlying venous thrombosis, most commonly of lower extremities and rarely.
Thrombophilia National Haemophilia Director
HICKMAN CATHETER Thrombotic complications associated with venous access devic Thrombotic complications associated with venous access devices Occlusion.
Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP
PHLEGMASIA Tracy Groller & Deb Halliday Journal Article Presentation MEDU 610 Professor: Camie Modjadidi April 7, 2011.
Hypercoagulable States. Acquired versus inherited Acquired versus inherited “Provoked” vs idiopathic VTE “Provoked” vs idiopathic VTE Who should be tested.
Thrombophilia. Definition –Tendency to develop clots due to predisposing factors that may be genetically determined.
Deep vein thrombosis Pulmonary embolism Deep vein thrombosis Pulmonary embolism Venous Thromboembolism TreatmentTreatment …All the same?
1 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University.
Chapter Seven Venous Disease Coalition Long-Term Management of VTE VTE Toolkit.
Welcome Applicants!! Welcome Applicants!! Morning Report Friday, October 28 th.
Duration of Anticoagulation 5 Patients Categories 3. First Episode: 4. First Episode: 5.Recurrent DVT 2. First Episode: 1. First Episode: Transient risk.
Low risk: young, with minor illnesses, who are to undergo operations lasting 30 min or less. Moderate risk: over 40 or with a debilitating illness who.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism ‘ The PADIS-PE Trial’ Nate Peyton.
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Outpatient DVT assessment & treatment Daniel Gilada.
Dep. Of Hemato-Oncology R1. Choi In-Ah D-dimer Testing to Determine the Duration of Anticoagulation Therapy Gualtiero Palareti,M.D., Benilde Cosmi, M.D.,
Venous thrombosis , why should I care ?
Deep Venous Thrombosis ROSENS EM MAJIDI ALIREZA RESIDENT OF EM SBMU
Nalaka Gunawansa MS, MCh (Edin) MD (Liv)
By: Dr. Nalaka Gunawansa
Complex Case Presentations. Complications and Management.
Dr Ferdous Mehrabian. Dr Ferdous Mehrabian Inherited thrombophilias in pregnancy Inherited thrombophilias is a genetic tendency to venous thrombosis.
HICKMAN CATHETER. HICKMAN CATHETER Thrombotic complications associated with venous access devices Occlusion of lumen Fibrin sheath formation Venous.
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
New Oral Anticoagulants and VTE Management
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Venous Thromboembolism (VTE)
How I treat cancer-associated venous thromboembolism
Thrombophilia.
Superior vena cava thrombosis in sickle cell trait patient Case study
Prevention and Management of Venous Thromboembolic Events in Patients With Multiple Myeloma.
Treatment algorithm. Treatment algorithm. (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE in cancer patients. (B) Suggested.
Presentation transcript:

Deep vein thrombosis

Color duplex scan of DVT

Venogram shows DVT

Patient with suspect symptomatic Acute lower extremity DVT Venous duplex scan negative Low clinical probability observe High clinical probability Repeat scan / Venography negative positive Evaluate coagulogram /thrombophilia/ malignancy Anticoagulant therapy contraindication yes IVC filter No pregnancy LMWH OPD LMWH hospitalisation UFH + warfarin Compression treatment

Thrombophilia screening Factor V leiden, Prot C/S deficiency Antithrombin III deficiency Idiopathic DVT < 50 years Family history of DVT Thrombosis in an unusual site Recurrent DVT

Recommendation for duration of warfarin 3-6 months first DVT with reversible risk factors At least 6 months for first idiopathic DVT 12 months to lifelong for recurrent DVT or first DVT with irreversible risk factors malignancy or thrombophilic state

Diagram 6

Phlegmasia cerulea dolens Venous gangrene

Catheter directed-thrombolysis Consider in: Acute< 10 days iliofemoral DVT. Long-term benefit in preventing post-phebitic syndrome is unknown.